Methods for treating patients who are candidates for inhaled nitric oxide treatment | Patent Number 08795741
US 08795741 B2Filled DateNov 21, 2012
Priority DateJun 30, 2009
Publication DateMar 28, 2013
Expiration DateJun 29, 2029
Inventor/ApplicantsJames S. Baldassarre
ExaminesARNOLD, ERNST V
Art Unit1613
Technology Center1600
Assignments
Meh Inc.
Current
Mallinckrodt Enterprises LlcCurrent
Ocera Therapeutics Llc Fka Ocera Therapeutics Inc.Current
Mallinckrodt International Finance S.a.Current
Cns Therapeutics Inc.Current
Specgx Llc MallinckrodtCurrent
Imc Exploration CompanyCurrent
Liebelflarsheim CompanyCurrent
Mallinckrodt Veterinary Inc.Current
Lafayette Pharmaceuticals LlcCurrent
Infacare Pharmaceutical CorporationCurrent
St Shared Services LlcCurrent
Mallinckrodt Finance GmbhCurrent
Mallinckrodt Carribean Inc.Current
Ludlow CorporationCurrent
Therakos Inc.Current
Ino Therapeutics MallinckrodtCurrent
Mallinckrodt Pharmaceuticals IrelandCurrent
Vtesse Llc Fka Vtesse Inc.Current
Ikaria Therapeutics LlcCurrent
MallinckrodtCurrent
Mallinckrodt Cb LlcCurrent
Mallinckrodt Enterprises Holdings LlcCurrent
Stratatech CorporationCurrent
Mallinckrodt Holdings B.v.Current
Mnk 2011 LlcCurrent
Sucampo Pharma LlcCurrent
Ino Therapeutics MallinckrodtMallinckrodtOriginal
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.